Global Medical REIT - GMRE Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $11.25
  • Forecasted Upside: 27.70%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$8.81
▼ -0.44 (-4.76%)

This chart shows the closing price for GMRE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Global Medical REIT Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GMRE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GMRE

Analyst Price Target is $11.25
▲ +27.70% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Global Medical REIT in the last 3 months. The average price target is $11.25, with a high forecast of $12.50 and a low forecast of $10.00. The average price target represents a 27.70% upside from the last price of $8.81.

This chart shows the closing price for GMRE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in Global Medical REIT. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/1/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/1/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/28/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/27/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/26/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/25/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/13/2024B. RileyLower TargetBuy ➝ Buy$11.00 ➝ $10.00Low
8/4/2023Compass PointBoost Target$11.00 ➝ $12.50Low
5/8/2023B. RileyLower Target$12.00 ➝ $11.00Low
5/4/2023Stifel NicolausLower Target$13.00 ➝ $11.00Low
3/6/2023B. RileyLower TargetBuy$14.00 ➝ $12.00Low
10/10/2022Robert W. BairdDowngradeOutperform ➝ NeutralLow
10/6/2022BMO Capital MarketsDowngradeOutperform ➝ Market PerformLow
8/15/2022Compass PointLower Target$17.00N/A
8/9/2022Compass PointLower Target$17.00N/A
7/7/2022JMP SecuritiesInitiated CoverageMarket PerformN/A
5/10/2022B. RileyLower Target$18.00 ➝ $16.00High
3/2/2022B. RileyLower Target$20.00 ➝ $18.00High
9/20/2021KeyCorpInitiated CoverageOverweight$17.00Low
7/9/2021Colliers SecuritiesInitiated CoverageBuy$18.00Medium
6/15/2021B. RileyBoost TargetBuy$16.00 ➝ $18.00Low
4/16/2021BMO Capital MarketsInitiated CoverageOutperform$16.00Medium
9/1/2020Stifel NicolausReiterated RatingBuy$15.00High
7/1/2020Berenberg BankInitiated CoverageBuy$13.00Medium
3/18/2020B. RileyUpgradeNeutral ➝ Buy$16.00 ➝ $12.00High
3/6/2020Robert W. BairdBoost TargetOutperform$14.00 ➝ $17.00Medium
3/6/2020B. RileyDowngradeBuy ➝ Neutral$15.00 ➝ $16.00High
3/5/2020Stifel NicolausBoost TargetBuy$14.00 ➝ $16.00High
2/7/2020National SecuritiesInitiated CoverageBuy$16.00Low
1/7/2020Janney Montgomery ScottUpgradeNeutral ➝ Buy$14.50Medium
12/20/2019B. RileyBoost TargetBuy$13.00 ➝ $15.00Medium
12/17/2019Stifel NicolausBoost TargetBuy$12.00 ➝ $14.00Low
(Data available from 6/24/2019 forward)

News Sentiment Rating

1.05 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/27/2023
  • 4 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/27/2023
  • 5 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/26/2024
  • 3 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/25/2024
  • 3 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/26/2024
  • 2 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/25/2024
  • 5 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/25/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/24/2024

Current Sentiment

  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

Global Medical REIT logo
Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Read More

Today's Range

Now: $8.81
Low: $8.77
High: $9.05

50 Day Range

MA: $8.73
Low: $7.98
High: $9.31

52 Week Range

Now: $8.81
Low: $7.98
High: $11.59

Volume

637,900 shs

Average Volume

392,472 shs

Market Capitalization

$577.85 million

P/E Ratio

38.30

Dividend Yield

9.08%

Beta

1.21

Frequently Asked Questions

What sell-side analysts currently cover shares of Global Medical REIT?

The following equities research analysts have issued stock ratings on Global Medical REIT in the last year: B. Riley, Compass Point, and StockNews.com.
View the latest analyst ratings for GMRE.

What is the current price target for Global Medical REIT?

2 Wall Street analysts have set twelve-month price targets for Global Medical REIT in the last year. Their average twelve-month price target is $11.25, suggesting a possible upside of 27.7%. Compass Point has the highest price target set, predicting GMRE will reach $12.50 in the next twelve months. B. Riley has the lowest price target set, forecasting a price of $10.00 for Global Medical REIT in the next year.
View the latest price targets for GMRE.

What is the current consensus analyst rating for Global Medical REIT?

Global Medical REIT currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe GMRE will outperform the market and that investors should add to their positions of Global Medical REIT.
View the latest ratings for GMRE.

What other companies compete with Global Medical REIT?

How do I contact Global Medical REIT's investor relations team?

Global Medical REIT's physical mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company's listed phone number is (202) 524-6851 and its investor relations email address is [email protected]. The official website for Global Medical REIT is www.globalmedicalreit.com. Learn More about contacing Global Medical REIT investor relations.